In a recent study based on ICARE participants, we compared cancer risk management between those with CHEK2 1100delC (which leads to moderate breast cancer risk, generally more than 20% lifetime risk) versus I157T (which is a low penetrance mutation, with breast cancer risks of less than 20%) 👩🔬 Of the 150 CHEK2 carriers, there were …
Tag: Genes
Permanent link to this article: https://inheritedcancer.net/post80524/
ICARE Social Media Post July 2024
New Study in POT1 Carriers
ICARE Social Media Post July 2024
New Study in POT1 Carriers
In recognition of Sarcoma Awareness Month, a new study found that POT1 mutations are associated with an increased risk for melanoma and a wider variety of different sarcomas than previously described. Specifically, the study showed significant raised risks of around 7-fold for both sarcoma and melanoma. This included many different types of sarcomas, including: Learn …
Permanent link to this article: https://inheritedcancer.net/post72824/
ICARE Social Media Post July 2024
New Genes Raise Breast Cancer Risks Identified in Study of African Women
ICARE Social Media Post July 2024
New Genes Raise Breast Cancer Risks Identified in Study of African Women
A new study, which included ICARE-related efforts through including BEST study participants:▪️ Identified 12 breast cancer genes that may help to predict breast cancer risk▪️ Included more than 40,000 women of African ancestry, almost half of which had breast cancer Why is studying individuals from diverse ancestral backgrounds important?▪️ Refine risks across diverse populations▪️ A …
Permanent link to this article: https://inheritedcancer.net/post72524/
ICARE Social Media Post June 2024
ICARE Post #3 – PALB2 Genomics Study Post
ICARE Social Media Post June 2024
ICARE Post #3 – PALB2 Genomics Study Post
If you have a history of breast cancer and a mutation in the PALB2 gene, you may be eligible to contribute to tumor genomics studies to help better understand inherited breast cancer in PALB2 carriers. Through the Inherited Cancer Registry (ICARE), we are studying: With your help, we hope that one day our research may …
Permanent link to this article: https://inheritedcancer.net/post71124/
ICARE Social Media Post June 2024
ICARE Post #3 – CHEK2 Genomics Study Post
ICARE Social Media Post June 2024
ICARE Post #3 – CHEK2 Genomics Study Post
If you have a history of breast cancer and a mutation in the CHEK2 gene, you may be eligible to contribute to tumor genomics studies to help better understand inherited breast cancer in CHEK2 carriers. Through the Inherited Cancer Registry (ICARE), we are studying: With your help, we hope that one day our research may …
Permanent link to this article: https://inheritedcancer.net/post7052024/
ICARE Social Media Post June 2024
Breast Cancer Patients with BRCA Variants Diagnosed Within 10 Years Postpartum at Higher Mortality Risk
ICARE Social Media Post June 2024
Breast Cancer Patients with BRCA Variants Diagnosed Within 10 Years Postpartum at Higher Mortality Risk
A new study reported that among BRCA carriers, breast cancer diagnosed within 10 years of having a child was associated with a higher risk of mortality, especially in BRCA1 carriers. This information could be important for genetic counseling, prevention, and treatment strategies in BRCA carriers. Learn more by reading the full article at: https://bit.ly/3wHyAIz Reference: …
Permanent link to this article: https://inheritedcancer.net/post60624/
ICARE Social Media Post June 2024
Pregnancy after Breast Cancer: BRCA carriers
ICARE Social Media Post June 2024
Pregnancy after Breast Cancer: BRCA carriers
A new study reported that pregnancy after breast cancer was not associated with adverse maternal prognosis or fetal outcomes. These findings suggest that pregnancy after breast cancer is safe for both mother and baby. Read the full article at: https://bit.ly/3wcoa3xReference: Newman, et al. JAMA Surg. 2024. Online ahead of print. PMID: 38536201. Follow us to …
Permanent link to this article: https://inheritedcancer.net/post60324/
ICARE Social Media Post May 2024
CHEK2: Bi-Allelic Mutations
ICARE Social Media Post May 2024
CHEK2: Bi-Allelic Mutations
Do you know the cancer risks for individuals with CHEK2 bi-allelic mutations (i.e., those with TWO CHEK2 mutations)? A new study found that risks may be higher for multiple types of cancer, including breast cancer, in both females and males ⤸▪️ Females more frequently developed 2 or more cancers at younger ages▪️ Males more frequently …
Permanent link to this article: https://inheritedcancer.net/post50324/